An advisory group meeting to verify the safety and effectiveness of AstraZeneca's COVID-19 vaccine will be held on the 31st of this month. In this meeting, external experts will participate in the clinical trial data. In addition, the Central Pharmaceutical Affairs Review Committee for COVID-19 treatment developed by Celltrion will be held on the 27th, and the results will be released on the same day.

The MFDS announced on the 21st the progress of COVID-19 vaccine and treatment review process.

Completed the survey on the actual condition of the SK Bioscience factory. Request for quality data and review for lot release

According to the MFDS, the AstraZeneca’s